Compare ADPT & TREX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ADPT | TREX |
|---|---|---|
| Founded | 2009 | 1996 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.6B | 5.3B |
| IPO Year | 2019 | 1998 |
| Metric | ADPT | TREX |
|---|---|---|
| Price | $27.73 | $50.00 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 8 | 20 |
| Target Price | $33.86 | ★ $63.05 |
| AVG Volume (30 Days) | 2.1M | ★ 2.2M |
| Earning Date | 11-04-2026 | 11-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 63.89 | N/A |
| EPS | N/A | ★ 1.70 |
| Revenue | $276,976,000.00 | ★ $1,174,267,000.00 |
| Revenue This Year | $10.85 | $10.59 |
| Revenue Next Year | $21.60 | $5.06 |
| P/E Ratio | ★ N/A | $29.76 |
| Revenue Growth | ★ 54.77 | 1.98 |
| 52 Week Low | $12.00 | $30.60 |
| 52 Week High | $32.21 | $60.21 |
| Indicator | ADPT | TREX |
|---|---|---|
| Relative Strength Index (RSI) | 49.06 | 46.61 |
| Support Level | $24.02 | $41.15 |
| Resistance Level | $29.92 | $50.04 |
| Average True Range (ATR) | 1.71 | 2.61 |
| MACD | -0.09 | -0.73 |
| Stochastic Oscillator | 31.91 | 2.85 |
Adaptive Biotechnologies Corp is a company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its clinical diagnostic product, clonoSEQ, is a test authorized by the FDA for the detection and monitoring of minimal residual disease (MRD) in patients with multiple myeloma (MM), B cell acute lymphoblastic leukemia (ALL) and chronic lymphocytic leukemia (CLL) and is also available as a CLIA-validated laboratory developed test (LDT) for patients with other lymphoid cancers. The company has two operating segments: Minimal Residual Disease and Immune Medicine. The company generates the majority of its revenue from the Minimal Residual Disease segment.
Trex Co Inc is a manufacturer of wooden alternative decking products. The company offers outdoor products in the decking, railing, porch, fencing, trim, steel deck framing, and outdoor lighting categories. Its products are sold under the Trex brand and manufactured in the United States. Further, the company licenses its Trex brand to third parties to manufacture and sell products under the Trex trademark. The distribution is focused on wholesale distributors and retail lumber dealers, which in turn sell Trex products to homeowners and contractors, with an emphasis on professional contractors, remodelers, and homebuilders. The company operates in one reportable segment i.e. Trex Residential.